This inventor holds 4 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 1998-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2002
Title: The Innovative Journey of Clint Duane Walker
Introduction: Clint Duane Walker, an accomplished inventor based in Indianapolis, Indiana, has made significant contributions to the field of pharmaceuticals. With a total of 4 patents to his name, Clint's work stands out for its impact on serotonin agonists and reuptake inhibitors.
Latest Patents: Clint's latest patents showcase his expertise in pharmaceutical innovation. One notable patent is on "Aminotetralins as 5-HT1D α Agonists," which introduces a novel class of aminotetralins that act as 5-HT agonists. Another important patent is on "Arylpiperazines as Serotonin Reuptake Inhibitors and 5-HT1D α Antagonists," further expanding the understanding of serotonin modulation.
Career Highlights: Clint Duane Walker is associated with Eli Lilly and Company, a renowned pharmaceutical firm known for its groundbreaking research. Through his work at Eli Lilly, Clint has been instrumental in developing cutting-edge pharmaceutical solutions that have the potential to improve the lives of many.
Collaborations: In his research endeavors, Clint has collaborated with esteemed colleagues such as Yao-Chang Xu and Michael E Flaugh. These collaborations have led to fruitful endeavors and enriched the pharmaceutical landscape with innovative solutions.
Conclusion: Clint Duane Walker's inventive spirit and dedication to pharmaceutical innovation have positioned him as a key figure in the field. His patents and collaborations reflect a commitment to advancing pharmaceutical research and developing novel solutions for complex medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile